Floatz logo

Dexasone

Adult Acute Lymphoblastic Leukemia

Shanxi Bethune HospitalSmall moleculePhase 4 / ApprovedActive
BBB
79/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
73/ 100
Competitive Position
89/ 100

Competitive context

65 Active assets in the Adult Acute Lymphoblastic Leukemia cohort.

Asset / SponsorPhaseRating
MERCAPTOPURINE ANHYDROUS
Shanxi Bethune Hospital
Phase 4A
Cytarabine
PETHEMA Foundation
Phase 4BBB
METHOTREXATE
PETHEMA Foundation
Phase 4BBB
Cyclophosphamide
The First Affiliated Hospital of Zhengzhou University
Phase 4BBB
Vindesine
Shanxi Bethune Hospital
Phase 4BBB

View all 50 →

Same molecule, other indications

Dexasone is also rated in:

chemotherapy-induced toxicityActive
A
Indicative · Phase 4
82 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative · Phase 3
78 / 100
View asset →
adult T-cell leukemia/lymphomaActive
BBB
Indicative · Phase 2
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →